immunogenicity


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to immunogenicity: humoral immunity

im·mu·no·gen·ic

 (ĭm′yə-nō-jĕn′ĭk, ĭ-myo͞o′-)
adj.
Capable of inducing an immune response.
im′mu·no·ge·nic′i·ty (-jə-nĭs′ĭtē)

immunogenicity

(ˌɪmjʊnəʊdʒɪˈnɪsɪtɪ)
n
the state of being immunogenic
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.immunogenicity - the property of eliciting an immune response
immunity, resistance - (medicine) the condition in which an organism can resist disease
Mentioned in ?
References in periodicals archive ?
Safety and immunogenicity of ABP 798 were comparable to Rituxan.
United States : Amgen And Allergan Announce Positive Top-Line Results From Comparative Clinical Study Of ABP 798, Biosimilar Candidate To Rituxan (Rituximab)
Although these SS DNA vaccines are superior over than conventional SS vaccines, the immunogenicity is still weak, and the effect of their growth-promoting of animals is not evident, especially in large animals.
Evaluation of the Fusion Type CpG Adjuvant for the Enhancement of Somatostatin DNA Vaccine in Ram Lambs
DREAMM-1 is a first-in-human and open-label study of GSK2857916 designed to evaluate the safety, pharmacokinetics, pharmacodynamics, immunogenicity and clinical activity of the antibody drug conjugate GSK2857916 in patients with relapsed/refractory multiple myeloma and other advanced hematologic malignancies expressing B-cell maturation antigen.
GlaxoSmithKline's GSK2857916 achieves 60% overall response rate in DREAMM-1 study
From 2008 until 2013 she was Head of the In Vitro Immunogenicity group at AlgoNomics (Ghent, Belgium) and Lonza Applied Protein Services (Cambridge, UK).
Challenges Facing Immuno-Oncology Industry Include Identifying Patients Before Therapy, Limited Responses, and Effective Biomarker Research
26 ZEBOV and MVA-BN-Filo have already been administered to 122 healthy adults in Kericho County and its environs.The randomised, observer-blind, placebo-controlled, phase 2 study was done to evaluate the safety, tolerability and immunogenicity of the two prime- vaccines.
Ebola vaccinetrials in Kenya 'in the last stages'
Cunningham, M.D., from the University of Sydney, and colleagues presented immunogenicity results from two trials involving patients aged 50 years or older and aged 70 years or older who received two doses of HZ/su or placebo two months apart.
Robust Immune Responses for Herpes Zoster Subunit Vaccine; Humoral response seen for 97.8 percent of HZ/su vaccine recipients versus 2 percent of placebo
From February 2016 to January 2018, the ACIP Hepatitis Vaccines Work Group ([dagger]) participated in three teleconference meetings to review the quality of evidence for immunogenicity and safety of HepB-CpG and implementation issues.
Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant
As biologic drug providers endeavor to create effective protein-based medicines, immunogenicity remains a complex challenge.
How can we predict immunogenicity earlier in drug discovery: scientists can make better-informed decisions and identify potential immune responses earlier by giving virtual and real experiments equal weight in the development of biotherapeutics
Immunogenicity is now known to be one of the main causes of this loss of response.
Importance of immunogenicity testing for cost-effective management of psoriasis patients treated with adalimumab
(3) Immunogenicity of 2 doses of the 9-valent HPV vaccine in girls and boys ages 9 to 14 was compared with that of a standard 3-dose regimen in adolescents and young women ages 16 to 26.
It is time for HPV vaccination to be considered part of routine preventive health care
In this Phase III, open-label study, we assessed the immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine (Fluarix[TM] Tetra) in Brazilian adults (NCT02369341).
Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil
The mechanisms for the development of response failure are complex; however, immunogenicity of these protein-based TNF antagonists has been recognized as a major factor (5).
Immunogenicity Assessment of Tumor Necrosis Factor Antagonists in the Clinical Laboratory

Dictionary browser ?
Full browser ?